Atomoxetine in the Treatment of Adolescent With Trichotillomania and Attention-Deficit/Hyperactivity Disorder

被引：5
|
作者：
Turkoglu, Serhat [1 ]
Cetin, Fatih Hilmi [1 ]
机构：
[1] Selcuk Univ, Fac Med, Dept Child & Adolescent Psychiat, Konya, Turkey
来源：
CLINICAL NEUROPHARMACOLOGY | 2018年 / 41卷 / 02期
关键词：
D O I：
10.1097/WNF.0000000000000273
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：84 / 85
页数：2
相关论文
共 50 条
  • [31] Cardiovascular Effects of Methylphenidate, Amphetamines and Atomoxetine in the Treatment of Attention-Deficit Hyperactivity Disorder
    Gary Stiefel
    Frank M.C. Besag
    Drug Safety, 2010, 33 : 821 - 842
  • [32] Guanfacine ER for the treatment of adolescent attention-deficit/hyperactivity disorder
    Bukstein, Oscar Gary
    Head, Jared
    EXPERT OPINION ON PHARMACOTHERAPY, 2012, 13 (15) : 2207 - 2213
  • [33] Methylphenidate and atomoxetine for treatment of nocturnal enuresis in a child with attention-deficit hyperactivity disorder
    Bahali, Kayhan
    Ipek, Hamiyet
    Uneri, Ozden Sukran
    EUROPEAN CHILD & ADOLESCENT PSYCHIATRY, 2013, 22 (10) : 649 - 650
  • [34] Atomoxetine for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in children with ADHD and dyslexia
    Sumner C.R.
    Gathercole S.
    Greenbaum M.
    Rubin R.
    Williams D.
    Hollandbeck M.
    Wietecha L.
    Child and Adolescent Psychiatry and Mental Health, 3 (1)
  • [35] Tolerability of atomoxetine for treatment of pediatric attention-deficit/hyperactivity disorder in the context of epilepsy
    Torres, Alcy
    Whitney, Jane
    Rao, Sneha
    Tilley, Claire
    Lobel, Rachel
    Gonzalez-Heydrich, Joseph
    EPILEPSY & BEHAVIOR, 2011, 20 (01) : 95 - 102
  • [36] Long-term atomoxetine treatment in adolescents with attention-deficit/hyperactivity disorder
    Wilens, Timothy E.
    Newcorn, Jeffrey H.
    Kratochvil, Christopher J.
    Gao, Haitao
    Thomason, Christine K.
    Rogers, Ann K.
    Feldman, Peter D.
    Levine, Louise R.
    JOURNAL OF PEDIATRICS, 2006, 149 (01): : 112 - 119
  • [37] Atomoxetine (Strattera®), an alternative in the treatment of attention-deficit/hyperactivity disorder (ADHD) in children
    Gaillez, C.
    Sorbara, F.
    Perrin, E.
    ENCEPHALE-REVUE DE PSYCHIATRIE CLINIQUE BIOLOGIQUE ET THERAPEUTIQUE, 2007, 33 (04): : 621 - 628
  • [38] Low-dose atomoxetine for maintenance treatment of attention-deficit/hyperactivity disorder
    Newcorn, Jeffrey H.
    Michelson, David
    Kratochvil, Christopher J.
    Allen, Albert J.
    Ruff, Dustin D.
    Moore, Rodney J.
    PEDIATRICS, 2006, 118 (06) : E1701 - E1706
  • [39] Atomoxetine treatment in children with attention-deficit/hyperactivity disorder and comorbid tic disorders
    Allen, AJ
    Kurlan, RM
    Linder, SL
    Lewis, DW
    Winner, PK
    Gilbert, DL
    Dunn, DW
    Sallee, FR
    Milton, DR
    Mintz, MI
    Ricardi, RK
    Erenberg, G
    Layton, LL
    Feldman, PD
    Kelsey, DK
    Spencer, TJ
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2004, 14 : S373 - S373
  • [40] Atomoxetine: The first nonstimulant for the management of attention-deficit/hyperactivity disorder
    Corman, SL
    Fedutes, BA
    Culley, CM
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2004, 61 (22) : 2391 - 2399
12345